Agata Bzymek-Waśniewska and Marta Sroka-Maleta jointly lead the team at DBS Law Firm; the former is noted for her broad expertise in sector-specific labour law issues, and promotional, logistics, and distribution issues within the pharmaceutical industry, while the latter is particularly active on mandates concerning changes to pharmaceutical, reimbursement and IP legislation. The ‘very well seasoned’ group exhibits deep regulatory knowledge of orphan drugs and international drug launches. Andrzej Siwiec was promoted to partner in January 2023, and has extensive regulatory knowledge, advising on a range of market access and business development projects.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘The team is very knowledgeable in the specialised life sciences regulations across the EU. Good practical advice without making matters excessively complex.’

  • ‘Andrzej Siwiec is always responsive, addresses queries promptly, has a good understanding of life sciences regulations, provides practical advice.’

  • ‘Here is a testimony to all the outstanding work they are all doing: I am grateful and appreciative of all the tenacious efforts, creative problem-solving and teamwork they all contribute.’

  • ‘Marta Sroka-Maleta is highly respected for her expertise in life sciences. In addition to advising companies from this sector, she also has a wealth of experience in important legislative projects. Andrzej Siwiec deserves praise for his commercial acumen combined with strong legal and technical skills.’

  • ‘Extensive litigation experience, strong understanding of the pharmaceutical sector, ability to provide business-oriented legal advice and exceptionally good collaboration.’

  • ‘Very well seasoned and deep knowledge of the pharma sector. Unique level of specialisation in pharma law field. Great responsiveness to the client's needs.’

  • ‘Marta Sroka-Maleta is a unique expert, who is very experienced in pharma IP and regulatory matters. She is inquisitive deep thinker who always sees all the implications of the matters at stake, as well as providing solutions.’

  • ‘Agata Bzymek-Waśniewska is experienced in handling all commercial and regulatory matters of pharma businesses. She has deep understanding of business needs.’

Key clients

  • Alpen Pharma Polska
  • Avanzanite Bioscience
  • GOFARM
  • Plich Advisory & Investments
  • Polski Lek (MASPEX group)
  • SESTEC
  • Teva Operations Poland
  • Teva Pharmaceuticals Polska
  • Your Health Medical Centre
  • Mokotooth Prestige Dental
  • Medicines for Poland
  • LEK-AM

Work highlights

  • Advising a global pharmaceutical corporation on a possible change to its business model in Poland.
  • Advising a Dutch pharmaceutical company on the preparation of a multi-jurisdictional launch and the commercialisation of a medicinal product for a rare disease.
  • Advising a pharmaceutical group on all legal issues connected with the marketing and advertising of its newly-launched product.

Practice head

The lawyer(s) leading their teams.

Agata Bzymek-Waśniewska, Marta Sroka-Maleta

Other key lawyers

Joanna Mączko-Forgiel, Andrzej Siwiec